LogicMark, Inc. Announces Strong Fourth Quarter and Full Year 2025 Results
Fourth Quarter and Full Year 2025 Financial Highlights
- Revenue: Fourth-quarter revenue increased 36% to
$3.1 million . Full-year revenue increased 15% to$11.4 million . Revenue has increased year-over-year in six of the last seven quarters. - Gross margin: Fourth quarter gross margin increased to 69.8%. Full-year gross margin remained strong at 66.8%.
- Operating expenses: Fourth quarter operating expenses increased modestly by
$0.1 million , or 3%, compared with the prior-year period. Full-year operating expenses increased by$1.2 million , or approximately 9%. - Cash and investments:
$9.5 million atDecember 31, 2025 , with no long-term debt.
Operational Highlights for 2025
- Continued expanding position in the growing personal emergency response and connected-care market, supported by favorable trends in aging in place, at-home care, and data-driven health monitoring.
- Advanced a differentiated portfolio of features and new service offerings, including no-fee monthly options, mobile-monitored, as well as mobile-first emergency button products.
- Furthered the Company’s strategy of moving from reactive alerting toward proactive, predictive care through AI, machine learning, IoT, and CPaaS-enabled capabilities.
- Expanded across healthcare, government, consumer, reseller, and B2B channels, supported by longstanding
Veterans Health Administration (VHA) relationships and a renewed five-year GSA contract.
In 2026, we will continue to focus on expanding distribution across healthcare, government, B2B, and consumer channels. We recently renewed our GSA contract, enhancing our access to federal procurement opportunities and supporting our longstanding partnership with the VHA. Together, we broaden our reach among veterans and other individuals served through government-supported care programs.
These innovative solutions complement our growing product portfolio, such as the Freedom Alert Max, launched last year. This new device incorporates enhanced health-tracking features, including medication reminders, activity monitoring, and caregiver-focused tools designed to improve engagement, safety, and independence.
Our investments continue to deepen customer engagement and broaden our revenue mix. With an expanded sales and business development team and multiple monetization pathways, including licensing of our vast IP portfolio, we believe
Fourth Quarter 2025 Results
Revenue for the fourth quarter ended December 31, 2025, was $3.1 million, up 36% compared with
Gross profit in the fourth quarter improved 43% to
Total operating expenses were
Net loss for the fourth quarter was
At the end of the fourth quarter of 2025, the Company reported cash and investments of
Full Year 2025 Results
Revenue for the year ended
Yearly gross profit improved 15% to
Total operating expenses for the full-year 2025 were
Net loss for the year was
The per-share figures reflect the impact of the reverse stock split completed in
Investor Call and SEC Filings
Ms.
To listen to the live webcast, please visit the LogicMark Investor Relations website or use the link: https://edge.media-server.com/mmc/p/74h4k6wc.
Analysts wishing to participate in the live call should register here: https://register-conf.media-server.com/register/BI1e9e6a77e11042d99f0e8da30dafa192.
The associated press release,
About
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management’s current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to, among other things, the Company’s financial results for the fourth quarter and full year 2025 and related call and webcast, and the successful execution of the Company’s business strategy. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the need and availability of financing; the Company’s ability to implement its long-range business plan for various applications of its technology; the Company’s ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company’s technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company’s reports filed with the SEC. There can be no assurance that a broker will continue to make a market in the Company’s common stock or that trading of the common stock will continue on an over-the-counter market or elsewhere. Should one or more of these risks or uncertainties materialize, or should assumptions underlying forward-looking statements prove incorrect, actual results may differ materially from those described in this press release as intended, planned, anticipated, believed, estimated, or expected. Any forward-looking statement made by us in this press release is based on information currently available to us and speaks only as of the date on which it is made. Except to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events, conditions, circumstances, or assumptions underlying such statements, or otherwise.
Investor Relations Contact
investors@logicmark.com
| BALANCE SHEETS | |||||||
| AS OF |
|||||||
| As of |
As of |
||||||
| 2025 | 2024 | ||||||
| Assets | |||||||
| Current Assets | |||||||
| Cash and cash equivalents | $ | 3,567,487 | $ | 3,806,915 | |||
| Investments | 5,943,218 | - | |||||
| Accounts receivable, net | 5,812 | 4,355 | |||||
| Inventory | 1,400,305 | 1,048,963 | |||||
| Prepaid expenses and other current assets | 681,265 | 476,672 | |||||
| Total Current Assets | 11,598,087 | 5,336,905 | |||||
| Property and equipment, net | 113,929 | 112,605 | |||||
| Right-of-use assets, net | 324,058 | 48,641 | |||||
| Product development costs, net of amortization of |
1,257,447 | 1,384,172 | |||||
| Software development costs, net of amortization of |
2,454,909 | 2,019,090 | |||||
| 3,143,662 | 3,143,662 | ||||||
| Other intangible assets, net of amortization of |
1,414,466 | 2,176,262 | |||||
| Total Assets | $ | 20,306,558 | $ | 14,221,337 | |||
| Liabilities, Series C Redeemable Preferred Stock and Stockholders’ Equity | |||||||
| Current Liabilities | |||||||
| Accounts payable | $ | 563,990 | $ | 750,336 | |||
| Accrued expenses | 1,128,424 | 1,053,301 | |||||
| Deferred revenue | 239,916 | 225,195 | |||||
| Total Current Liabilities | 1,932,330 | 2,028,832 | |||||
| Other long-term liabilities | 282,899 | - | |||||
| Total Liabilities | 2,215,229 | 2,028,832 | |||||
| Commitments and Contingencies (Note 9) | |||||||
| Series C Redeemable Preferred Stock | |||||||
| Series C redeemable preferred stock, par value |
1,807,300 | 1,807,300 | |||||
| Stockholders’ Equity | |||||||
| Preferred stock, par value |
|||||||
| Series F preferred stock, par value |
319,000 | 319,000 | |||||
| Series H preferred stock, par value |
- | 472,245 | |||||
| Series I preferred stock, par value |
- | - | |||||
| Common stock, par value |
91 | - | |||||
| Additional paid-in capital | 132,597,001 | 118,758,596 | |||||
| Accumulated deficit | (116,632,063 | ) | (109,164,636 | ) | |||
| Total Stockholders’ Equity | 16,284,029 | 10,385,205 | |||||
| Total Liabilities, Series C Redeemable Preferred Stock and Stockholders’ Equity | $ | 20,306,558 | $ | 14,221,337 | |||
| STATEMENT OF OPERATIONS | |||||||||||||||
| FOR THE YEARS ENDED |
|||||||||||||||
| For the Three Months Ended |
For the Years Ended |
||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Revenues | $ | 3,065,348 | $ | 2,249,174 | $ | 11,425,463 | $ | 9,901,987 | |||||||
| Costs of goods sold | 926,340 | 756,977 | 3,794,862 | 3,285,994 | |||||||||||
| Gross Profit | 2,139,008 | 1,492,197 | 7,630,601 | 6,615,993 | |||||||||||
| Operating Expenses | |||||||||||||||
| Direct operating cost | 356,351 | 328,044 | 1,420,813 | 1,338,758 | |||||||||||
| Advertising cost | 111,082 | 155,555 | 403,494 | 557,783 | |||||||||||
| Selling and marketing | 948,014 | 485,361 | 3,020,660 | 2,277,698 | |||||||||||
| Research and development | 162,324 | 154,512 | 617,369 | 558,621 | |||||||||||
| General and administrative | 1,593,739 | 2,016,614 | 7,857,086 | 7,626,124 | |||||||||||
| Other expense | 94,627 | 62,542 | 169,992 | 317,313 | |||||||||||
| Depreciation and amortization | 542,053 | 484,082 | 2,040,479 | 1,610,427 | |||||||||||
| Total Operating Expenses | 3,808,189 | 3,686,710 | 15,529,893 | 14,286,724 | |||||||||||
| Operating Loss | (1,669,181 | ) | (2,194,513 | ) | (7,899,292 | ) | (7,670,731 | ) | |||||||
| Other Income | |||||||||||||||
| Interest income | 79,867 | 26,378 | 397,658 | 160,664 | |||||||||||
| Other income (expense), net | 5,903 | (1,523,460 | ) | 49,060 | (1,483,732 | ) | |||||||||
| Total Other Income (Expense), Net | 85,771 | (1,497,082 | ) | 446,718 | (1,323,068 | ) | |||||||||
| Loss before Income Taxes | (1,583,411 | ) | (3,691,594 | ) | (7,452,574 | ) | (8,993,799 | ) | |||||||
| Income tax expense | 14,853 | 9,946 | 14,853 | 9,946 | |||||||||||
| Net Loss | $ | (1,598,264 | ) | $ | (3,701,540 | ) | $ | (7,467,427 | ) | $ | (9,003,745 | ) | |||
| Preferred stock dividends | (75,000 | ) | (75,000 | ) | (300,000 | ) | (300,000 | ) | |||||||
| Net Loss Attributable to Common and Participating Preferred Stockholders | $ | (1,673,264 | ) | $ | (3,776,540 | ) | $ | (7,767,427 | ) | $ | (9,303,745 | ) | |||
| Net Loss Attributable to Common and Participating Preferred Stockholders Per Share - Basic and Diluted | $ | (1.96 | ) | $ | (1,349.73 | ) | $ | (13.06 | ) | $ | (10,971.40 | ) | |||
| Weighted Average Number of Common Shares Outstanding - Basic and Diluted | 854,087 | 2,798 | 594,946 | 848 | |||||||||||
Source: LogicMark, Inc.